Connor, Clark & Lunn Investment Management (CC&L)
RUBY

Connor, Clark & Lunn Investment Management (CC&L)’s Rubius Therapeutics, Inc RUBY Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RUBY Stock Details RUBY Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-353,813
Closed -$301K – 1284
2022
Q2 		$301K Buy
353,813
+296,886
+522% +$253K ﹤0.01% 863
2022
Q1 		$314K Buy
+56,927
New +$314K ﹤0.01% 866